Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial. Lancet Oncol. 2015;16(15):1463–72. Article CAS PubMed Google Scholar Cleeland CS. The brief pain inventory user guide...
Surgery was the first line of treatment, therefore other clinical variables relating to adjuvant therapies, chemotherapy and/or radiotherapy are not reported in this manuscript. Participant recruitment Recruitment and consent was undertaken following diagnosis at breast clinics and screening centres, or ...
Chemo & Radiotherapy symptom management Cancer support Low Immunity“ I see Heather for allergies and gut disorders which she has managed to alleviate completely. “ Conditions regularly seen at the clinic The following are regularly seen at the clinic. If your condition or concern is not on ...
Cardiff University and North East Wales NHS Trust, Nephrology, Cardiff, Wrexham, UKMalcolm MasonVelindre Hospital, Clinical Oncology, Cardiff, UKJohn Wiley & Sons, LtdSze WM, Shelley M, Held I, et al. Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy - a ...
Clinical information was obtained from the hospital notes including: primary surgery; adjuvant chemotherapy regimens; radiotherapy details; and the type(s) of hormone therapy prescribed. Previous diagnoses of arthritis, fibromyalgia, and menopause status were not collected as this is not accurately ...
Oral capecitabine at a dose of 825 mg.m−2 was given twice daily on radiotherapy days. No patient received brachytherapy. After completing neoadjuvant chemoradiation therapy, all patients were assigned to the exercise group by default (i.e., there was no allocation concealment) by the ...
14 (40%) had previous radiotherapy; 18 (51%) previous chemotherapy. 15 (42%) were still on endocrine treatment at the time of lipomodelling. 27 (77%) took pain killers and/or other regular medication ranging from ibuprofen to gabapentin and amitriptyline. All patients were assessed before ...
Ineligible patients were candidates for PARP inhibition or had received prior systemic radiotherapy, immunotherapy or chemotherapy. Patients were randomized 1:1 to open-label177Lu-PSMA-617 (7.4 GBq/6 weeks; 6 cycles) or ARPI change (abiraterone/enzalutamide). Patients with confirmed radiographic ...
Comparing Pain Control and Ability to Eat and Drink with Standard Therapy vs Gel- clair: A Preliminary, Double Centre, Randomised Controlled Trial on Patients with Radiotherapy-induced Oral Mucositis [J]. Support Care Cancer,2007,15(4):427-440.DOh 10.1007/ s00520-006-0171-1....
N.; Smith, A.; et al. Development of a novel remote patient monitoring system: The advanced symptom management system for radiotherapy to improve the symptom experience of patients with lung cancer receiving radiotherapy.Cancer Nurs.2015,38, E37–E47. [Google Scholar] [CrossRef] [Green Version...